In the most recent year (2023) the Audit Committee convened 7 meetings. The attendance of independent directors is as follows:
|
Title |
Name |
Actual Attendance |
Entrusted to Attend Frequency |
Attendance Rate (%) |
|---|---|---|---|---|
|
Independent Director |
Yang Yung Cheng |
7 |
0 |
100.00 |
|
Independent Director |
Lee Wen Chuan |
7 |
0 |
100.00 |
|
Independent Director |
Juan Chiung Hua |
7 |
0 |
100.00 |
|
Independent Director |
Ho Chia Fang |
7 |
0 |
100.00 |
If the operation of the audit committee is in any of the following circumstances, the date, period, proposal content, resolution of audit committee and the company’s handling of independent committee members ‘opinions shall be stated:
- The matters listed in Article 14(5) of Securities and Exchange Act:
|
Session |
Date |
Meeting Content |
Resolutions and the Company’s handling to Audit Committee's opinions |
|---|---|---|---|
|
6th time of the 5th committee |
2023.02.07 |
Approval of Indonesian joint venture company PT All Cosmos Biotek's (PT Biotek) factory construction case. |
All presented members approved without objection and submitted to the board of directors for discussion. |
|
7th time of the 5th committee |
2023.03.22 |
|
All presented members approved without objection and submitted to the board of directors for discussion. |
|
8th time of the 5th committee |
2023.05.11 |
Approval of consolidated financial statements for the first quarter of 2023. |
All presented members approved without objection and submitted to the board of directors for discussion. |
|
9th time of the 5th committee |
2023.08.01 |
Joint venture partner YPJ intends to increase shareholding ratio of jointly invested Indonesian subsidiary PTACB. |
All presented members approved without objection and submitted to the board of directors for discussion. |
|
10th time of the 5th committee |
2023.08.25 |
Approval of consolidated financial statements for the second quarter of 2023. |
All presented members approved without objection and submitted to the board of directors for discussion. |
|
11th time of the 5th committee |
2023.11.10 |
|
All presented members approved without objection and submitted to the board of directors for discussion. |
- Other resolutions that have not been approved by the Audit Committee but have been approved by more than two-thirds of all directors in addition to previous matters: None
- The implementation of independent directors' avoidance of the proposal of interest, should state independent director’s name, contents of proposal, reasons for avoidance, participation and voting status: None.